Differences of regional homogeneity and cognitive function between psychotic depression and drug-naïve schizophrenia Authors: Wensheng Chen, Caixia Xu, Weibin Wu, Wenxuan Li, Wei Huang, Zhijian Li, Xiaoling Li, Guojun Xie, Xuesong Li, Chunguo Zhang, Jiaquan Liang Published: 2024 ABSTRACT AbstractBackgroundPsychotic depression (PD) and schizophrenia (SCZ) share overlapping symptoms yet differ in etiology, progression, and treatment approaches. Differentiating these disorders through symptom-based diagnosis is challenging, emphasizing the need for a clearer understanding of their distinct cognitive and neural mechanisms.AimThis study aims to compare cognitive impairments and brain functional activities in PD and SCZ to pinpoint distinguishing characteristics of each disorder.MethodsWe evaluated cognitive function in 42 PD and 30 SCZ patients using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and resting-state functional magnetic resonance imaging (rs-fMRI). Regional homogeneity (ReHo) values were derived from rs-fMRI data, and group differences in RBANS scores were analyzed. Additionally, Pearson correlation analysis was performed to assess the relationship between cognitive domains and brain functional metrics.Results(1) The SCZ group showed significantly lower RBANS scores than the PD group across all cognitive domains, particularly in visuospatial/constructional ability and delayed memory (p < 0.05); (2) The SCZ group exhibited a significantly higher ReHo value in the left precuneus compared to the PD group (p < 0.05); (3) A negative correlation was observed between visuospatial construction, delayed memory scores, and the ReHo value of the left precuneus.ConclusionCognitive impairment is more pronounced in SCZ than in PD, with marked deficits in visuospatial and memory domains. Enhanced left precuneus activity further differentiates SCZ from PD and correlates with cognitive impairments in both disorders, providing neuroimaging-based evidence to aid differential diagnosis and insights into cognitive dysfunction mechanisms, while also paving a clearer path for psychiatric research.Keywords: Psychotic depression, Schizophrenia, ReHo, Rs-fMRI, Cognition Introduction Schizophrenia (SCZ) is a persistent and disabling mental disorder that affects 1% of the global population, typically characterized by a range of positive, negative, and cognitive symptoms [1, 2]. To what extent SCZ disrupts an individual’s functioning in daily life varies. Some are able to perform at a high level, including work and social abilities, while others experience severe disability due to the severity of their symptoms [3]. Research findings suggest that SCZ is most common in the late adolescence and early adulthood, in the second and third decades of life [4]. That is to say, SCZ is often accompanied by significant declines in social and cognitive functioning rather than presenting solely as psychosis [5, 6]. Although hallucinations and delusions, which are a hallmark of the disease, are the most recognizable symptoms, several studies indicate that cognitive deficits typically manifest before the onset of psychosis and serve as a dependable prognostic indicator for long-term social functioning outcomes [7, 8]. Therefore, an increasing number of studies have placed increasing emphasis on investigating cognitive impairments in SCZ [9, 10]. Major Depressive Disorder (MDD) with psychotic features (psychotic depression, PD) is a severe disabling illness with a high risk of suicide [11, 12]. It is characterized by meeting the criteria for severe depression and exhibiting psychotic features such as hallucinations or delusions during a major depressive episode. Symptoms often include nihilistic delusions, excessive self-criticism, or beliefs of guilt [13]. Epidemiological studies of PD have found that the lifetime prevalence of PD varies between 0.35% and 1%, with higher rates observed in the elderly population [14]. Research on cognitive impairment in depression has revealed that PD tends to exhibit more severe symptoms compared to non-psychotic depression [15–17]. Moreover, among young adult patients with PD, they demonstrated, on average, worse cognitive performance across all cognitive domains compared to those who only have depression without psychotic features [18, 19]. SCZ and PD are two mental disorders that share common features of psychotic symptoms, such as delusions, hallucinations, or both, as well as severe impairment in occupational functioning. Compared to non-psychotic major depression patients and healthy controls, patients with PD exhibited more severe cognitive impairments in attention, cognitive inhibition, and verbal memory [15, 20]. At present, there is no consensus on whether there are cognitive differences between patients with SCZ and PD. It is worth noting that while both disorders share some clinical similarities, there are distinct differences in their cognitive symptoms and neural mechanisms, which can lead to diagnostic confusion in clinical practice. The search for neurobiological markers that help diagnose and distinguish disease has been a focus of research efforts [21]. Resting-state functional magnetic resonance imaging (rs-fMRI) is a non-invasive neuroimaging technique that has become an important tool for investigating functional connectivity in the brain, particularly in the context of psychiatric disorders [22, 23]. Regional homogeneity (ReHo) is a metric that assesses the degree of similarity between the time series of a particular voxel and those of its closest neighboring voxels within a single region of the brain, and is a valuable indicator of local temporal synchrony in the brain [24]. The ReHo method is a dependable tool for assessing brain activity, which can be utilized to explore alterations in brain function resulting from both normal development and pathological states. According to this method, previous studies have indicated the presence of widespread ReHo abnormalities in mental disorders. For example, compared to healthy controls, patients with SCZ exhibit increased ReHo values in the right frontal cortex [25] or in regions of the somatosensory and perception networks [26], and decreased ReHo values in regions of the visual cortex [27]. In addition, research has shown that PD may be associated with reduced functional connectivity (FC) in the frontoparietal network [28]. At the same time, there is a significant relationship between white matter microstructure and PD [29]. Research has shown that dynamic FC from resting-state electroencephalography can distinguish between psychotic major depression and schizophrenia [30]. However, to our knowledge, there are currently no comparative studies on PD and SCZ based on ReHo. Research in neuroimaging studies of psychiatric disorders is increasingly focusing on the precuneus [31, 32]. Situated in the medial region of the superior parietal cortex, the precuneus plays a role in episodic memory, visuospatial processing, self-reflection, and consciousness aspects [33, 34]. Numerous neurological and psychiatric conditions, including Alzheimer’s disease, mild cognitive impairment [35, 36], and depression [37, 38], have frequently reported structural and functional abnormalities in the precuneus. In the context of schizophrenia, several studies have identified significant FC abnormalities in this area [32, 39]. Currently, there are no studies focusing on the precuneus in PD, and this specific brain region may become one of the key indicators for distinguishing between PD and SCZ. We hypothesize that PD and SCZ differ in a certain core brain region, which is closely related to cognitive dysfunction. In light of this, we employed a combination of cognitive function assessment and functional imaging techniques to investigate cognitive impairment and neuroimaging differences between drug-naïve patients with SCZ and PD. The goal of this study was to provide a theoretical foundation for the clinical diagnosis and differentiation of these two disorders. Method Participants From January 2019 to October 2022, SCZ/PD patients who received treatment in the Department of Psychiatry at the Third People’s Hospital of Foshan, China, were included in this study, regardless of whether they were inpatients or outpatients. Clinically relevant information was obtained through interviews with clinicians. Inclusion criteria were as follows: (1) a diagnosis of SCZ/PD based on the criteria of the Structured Clinical Interview for DSM-IV-TR (SCID); (2) aged between 18 and 45 years; (3) education of at least 9 years; (4) Han ethnicity and right-handedness; (5) drug-naïve and a disease course of ≤ 2 years from the time of initial diagnosis. Exclusion criteria included the presence of other mental illnesses, brain organic and physical disorders, a family history of mental illness, substance abuse (drugs, alcohol), brain trauma, neurological diseases. All participants volunteered to take part in this study and were screened for contraindications to magnetic resonance imaging (MRI). We obtained written informed consent from each patient before conducting the MRI scan. This study was approved by the ethics committee of the Third People’s Hospital of Foshan and conducted in accordance with the principles of the Declaration of Helsinki. Assessments Scale evaluations were conducted using the following methods: (1) The Positive and Negative Syndrome Scale (PANSS) [40] was utilized to assess SCZ symptoms, while the Hamilton Depression Scale-24 items (HAMD) [41] was used to evaluate the PD group. (2) Cognitive function was assessed using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) [42]. The subjects were provided with standardized instructions and guidance regarding the evaluation rules. Imaging data acquisition Rs-fMRI was conducted using a Signa Pioneer 3.0T MR scanner from General Electric Company in the United States. Participants were instructed to remain supine with their eyes closed and to maintain a clear level of consciousness throughout the scan. T1-weighted structural images were acquired using the following scanning parameters: repetition time (TR) = 2000 ms, echo time (TE) = 30 ms, flip angle (FA) = 90º, field of view (FOV) = 240 mm × 240 mm, matrix = 64 × 64, slice thickness = 4 mm, gap = 1 mm, and 250 continuous time points were collected. High-resolution T1-weighted images were acquired using the following parameters: TR = 8.6 ms, TE = 3.3 ms, FA = 12°, FOV = 256 mm × 256 mm, matrix = 256 × 256, slice thickness = 1 mm, no gap between slices, and a total of 172 slices. Data preprocessing: DPARSF system (http://www.rfmri.org/DPARSF) was used to preprocess all image data. The first 10 sequences of images were deleted to exclude the influence of machine start-up on signal collection, and the remaining 240 sequences were used for data analysis. The preprocessing process included head movement correction and spatial standardization. According to the head movement correction curve, the data of 5 subjects with head movement translation > 2 mm and rotation > 2.5° were eliminated. The resting functional image was re-registered with T1 image, and then the imaging data were normalized to the Montreal Neurological Institute (MNI) space, and resampled to 3 × 3 × 3 mm3 resolution. ReHo analysis ReHo analysis was performed using a 27-voxel cluster size, and the Kendall coefficient of concordance (KCC) was used as an indicator to measure the local consistency of each voxel and its 26 nearest neighbors. The default standard brain model provided by the DPARSF software was used to obtain KCC maps for each subject. The KCC values were standardized by dividing them by the mean value in the standard brain model. The resulting mReHo maps were then spatially smoothed [43]. Statistical analysis The clinical scale scores were analyzed using SPSS 20 (https://www.ibm.com/analytics/spss-statistics-software). The normal distribution of measurement data from both the SCZ and PD groups was confirmed using the Kolmogorov-Smirnov (K-S) test. Two-sample t-tests were conducted on standardized ReHo images using SPM 8 software (https://www.fil.ion.ucl.ac.uk/spm/software/spm8). Take the age and education factors as covariates, then Pearson correlation analysis was performed to investigate the relationship between cognitive function scores and ReHo values in different brain regions. Finally, p values were corrected for multiple comparisons using Gaussian Random Field Theory (GRF) correction. (Fig. 1) The research flowchart Result Clinical data and cognitive function test This study included a total of 84 participants, including 42 patients with PD, and 42 patients with SCZ. Due to symptoms such as claustrophobia exhibited by 12 patients with SCZ who did not cooperate with the examination, they were excluded from the group. Gender distribution did not significantly differ between the PD and SCZ groups (p > 0.05). However, significant differences were observed in age, years of education, course of disease, and various cognitive domains of the RBANS test, including immediate memory (learning and story memory), visuospatial construction, language, attention (digit span), and delayed memory (list recall, list recognition, story recall, and figure recall) (p < 0.05). Overall, cognitive impairment in SCZ patients is more severe than that in psychotic PD patients. Please refer to Table 1 for detailed information. Table 1Clinical data and RBANS test between PD and SCZPDPD (95%CI)SCZSCZ(95%CI)Χ2 / t p Participants4230--Age (years)37.633 ± 10.039[33.884,41.382]26.714 ± 11.589[22.063,29.879]21.798< 0.001Gender (m/f)17 / 2514 / 160.2740.601Education12.771 ± 3.059[11.72,13.822]10.366 ± 1.134[9.196,11.537]28.499< 0.001HAMD25.047 ± 5.323[23.495,27.247]---PANSS-77.466 ± 16.596[71.269,83.663]--RBANSImmediate memory (Learning)27.487 ± 6.237[25.151,29.648]18.400 ± 6.815[15.854,20.945]25.323< 0.001Immediate memory (Story Memory)13.609 ± 5.761[11.506,15.636]6.000 ± 4.623[4.273,7.726]13.489< 0.001Visuospatial Construction18.658 ± 2.128[18.064,19.478]16.200 ± 4.188[14.635,17.764]44.062< 0.001Language17.365 ± 4.515[16.029,19.17]11.066 ± 4.578[9.357,12.776]22.563< 0.001Attention (Digit span)13.951 ± 2.626[12.917,14.796]11.100 ± 2.577[10.137,12.062]36.4< 0.001Attention (Coding)47.292 ± 12.613[42.302,50.897]25.866 ± 12.778[21.095,30.638]19.53< 0.001Delayed memory (List Recall)6.439 ± 2.966[5.213,7.357]3.100 ± 2.695[2.093,4.106]12.893< 0.001Delayed memory (List Recognition)19.536 ± 1.074[19.091,19.879]17.133 ± 3.329[15.89,18.376]60.374< 0.001Delayed memory (Story Recall)7.750 ± 3.739[6.449,9.15]3.166 ± 2.640[2.18,4.152]12.081< 0.001Delayed memory (Figure Recall)14.075 ± 4.034[12.652,15.575]9.200 ± 6.155[6.901,11.498]18.002< 0.001Note: PD psychotic depression; SCZ schizophrenia; HAMD Hamilton Depression Scale-24items; PANSS Positive and Negative Syndrome Scale; RBANS Repeatable Battery for the Assessment of Neuropsychological Status; Values are expressed as mean ± standard deviation Clinical data and RBANS test between PD and SCZ Note: PD psychotic depression; SCZ schizophrenia; HAMD Hamilton Depression Scale-24items; PANSS Positive and Negative Syndrome Scale; RBANS Repeatable Battery for the Assessment of Neuropsychological Status; Values are expressed as mean ± standard deviation ReHo Compared with SCZ, the left precuneus showed a significant difference in PD (Peak coordinates of − 9, − 72, 39; t = 5.634, voxel size = 27, p < 0.05, GRF correction, two-tailed). This indicates that changes in the ReHo values of the left precuneus may serve as one of the indicators for distinguishing between SCZ and PD patients. (Fig. 2) Regional homogeneity (ReHo) abnormalities in SCZ compared with PD, SCZ > PD. (A) The left precuneus, t = 5.634, cluster size = 27; pcluster < 0.05, two-tailed, GRF correction Pearson correlation analysis The ReHo values of the left precuneus were negatively correlated with visuospatial construction and delayed memory (List recognition) score (rvisuospatial construction = -0.287, p = 0.015; rdelayed memory (List Recognition) = -0.256, p = 0.031), those were performed in the combined SCZ and PD sample. This indicates that changes in the ReHo values of the left precuneus can affect visuospatial construction and delayed memory. (Fig. 3) A/B The ReHo values of the left precuneus were negatively correlated with visuospatial construction and delayed memory (List recognition) score (rA = -0.287, pA = 0.015; rB = -0.256, pB = 0.031) Discussion The results of this study showed that SCZ patients had lower cognitive function than PD patients. Compared to PD patients, SCZ patients had higher ReHo values in the left precuneus. Furthermore, the left precuneus ReHo values were negatively correlated with visuospatial construction and delayed memory (list recognition) scores, it also proved that SCZ patients and PD patients had differences in visuospatial construction and delayed memory. In both SCZ and PD, cognitive impairments are a common symptom [44–47]. However, there are differences in cognitive impairments between these two disorders. Cognitive impairments in patients with SCZ typically manifest as more severe deficits in attention, working memory, executive function, and inhibitory control [48, 49]. Additionally, individuals with SCZ may experience disturbances or disorders of consciousness, which can have a significant impact on cognitive functioning [50]. In contrast, the severity of cognitive impairments in patients with PD may be relatively mild [14]. Additionally, patients may exhibit impairments in working memory, executive function, and inhibitory control. Individuals with PD typically maintain a clear level of consciousness and do not experience disturbances or disorders of consciousness [51, 52]. Our study indicates that the cognitive test scores of individuals with SCZ were lower than those of individuals with PD, which is consistent with previous research and suggests that cognitive impairments in SCZ are more severe than in PD. The study demonstrates that as depressive symptoms subside, cognitive function can be significantly improved in PD patients [53]. However, cognitive impairment in SCZ is generally considered irreversible [54, 55]. Therefore, cognitive testing can be helpful in distinguishing between the diagnoses of these two diseases. Our study demonstrated that compared to PD, SCZ had higher ReHo values in the left precuneus. The precuneus, located in the posterior superior region of the cerebral hemisphere, is a major functional area of the brain involved in various cognitive functions such as spatial perception, visual-spatial processing, memory, emotion, and consciousness [56–58]. In neuroscience research, the functional activity of the precuneus is frequently measured and explored, and it is also often of interest in studies of psychiatric disorders [59–62]. The activation of the precuneus is associated with the vividness of judgments during episodic memory retrieval [63]. Research has demonstrated that individuals with SCZ who experience auditory verbal hallucinations exhibit increased spontaneous neural activity in the left precuneus region compared to healthy controls, resulting in elevated ReHo values [64]. Recent structural and functional MRI studies have often highlighted abnormalities in the precuneus associated with MDD. Previous research has reported reductions in the precuneus’s volume [65], white matter fiber connectivity to the anterior cingulate gyrus [66], and cortical gyrification [67]. Additionally, investigations into functional abnormalities revealed that spontaneous neural activity in the precuneus, as assessed by Low-frequency amplitude and ReHo, is compromised in patients with MDD [68, 69]. However, there are currently no studies on the precuneus in PD. We have found that the more severe the cognitive impairment, the more prominent the neural activity in the left precuneus. The left precuneus is a central brain region of the default mode network (DMN) and an important hub of the resting-state brain connectivity network that underlies human cognitive functions. Therefore, changes in the functional connectivity of the left precuneus may serve as an indicator to differentiate between cognitive impairments in patients with SCZ and those with PD. These findings will provide new depth and perspective to psychiatric research, contributing to a deeper understanding of the pathological mechanisms of mental disorders and potentially offering important theoretical foundations for future diagnostic and treatment strategies. We conducted a correlation analysis between the cognitive scores in RBANS and the ReHo values of the left precuneus. The results showed a significant negative correlation between the abnormal signal in the brain region and the scores of visuospatial construction and delayed memory. Research has found that patients with SCZ exhibit abnormal behavioral patterns and inflexible eye movement strategies in visuospatial problem-solving tasks [70]. And other researches had shown that patients with SCZ exhibit significant declines in visual spatial ability [71–73], as well as significant deterioration in delayed memory [74, 75]. This leads to a poorer prognosis for SCZ [76] and may be one of the factors contributing to the worse prognosis of SCZ compared to PD. As is well known, the precuneus is one of the main integration centers of functional and structural processes in the human brain, playing an important role in visual-spatial integration, memory, and self-awareness [77]. At the same time, it also links visual information with other brain processing systems involved in executive functions. Research has shown that when patients have focal brain damage in the precuneus, their cognitive function can be impaired to varying degrees [56, 78], which further supports our point. In summary, cognitive function tests are the important indicators of differences between PD and SCZ in clinical practice. Abnormal activity in the left precuneus may be a core brain region that distinguishes PD from SCZ and is closely related to cognitive impairment. However, this study does have some limitations. Firstly, the evidence supporting the left precuneus as a specific brain region for PD and SCZ cannot be universally substantiated [79, 80], which may be attributed to variations in the populations enrolled in different studies. Secondly, considering the exclusion of participants due to claustrophobia, future studies may explore alternative methods to accommodate these patients, aiming to prevent sample bias. Thirdly, the cross-sectional observational design limits our ability to establish causality regarding the observed differences, highlighting the need for long-term longitudinal research to draw more definitive conclusions. Therefore, caution should be exercised when interpreting these findings. In future studies, it is crucial to track changes in the left precuneus over time among patients with PD and SCZ, as this will further deepen the research on PD and SCZ. Acknowledgements Not applicable. Abbreviations Psychotic depression Schizophrenia Major depressive disorder Resting-state functional magnetic resonance imaging Regional homogeneity The structured clinical interview for DSM-IV-TR Magnetic resonance imaging The Positive and Negative Syndrome Scale The Hamilton Depression Scale-24 items The Repeatable Battery for the Assessment of Neuropsychological Status The Kendall coefficient of concordance Author contributions Chunguo Zhang: Writing - original draft, Writing - review & editing, Methodology, Software. Caixia Xu, Weibin wu, Wenxuan Li, Wei Huang, Zhijian Li, Xiaoling Li, Guojun Xie, Xuesong Li: Validation, Investigation, Resources. Wensheng Chen, Jiaquan Liang: Supervision, Project administration, Funding acquisition. Funding This study was supported by the project of the Guangdong Medical Science and Technology Research Fund (2023109102311656), Foshan Science and Technology Bureau (2220001004473, 2220001004879) and the Foshan “14th five-year plan” medical high level key psychiatric specialty construction project (FSGSP145069). Data availability The datasets generated and/or analyzed during the current study are not publicly available due to privacy and ethical restrictions but are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate All participants signed an informed consent at the time of enrollment, and this study was approved by the Ethics Committee of Foshan Third People’s Hospital. Consent for publication No individual data is presented, and consent to publication is therefore not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Wensheng Chen is First author and Caixia Xu is Co first author. Contributor Information Chunguo Zhang, Email: cgzhang1994@163.com. Jiaquan Liang, Email: 417891714@qq.com. References Associated Data Data Availability Statement The datasets generated and/or analyzed during the current study are not publicly available due to privacy and ethical restrictions but are available from the corresponding author on reasonable request.